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ABSTRACT
Laryngeal sarcomas constitute an extremely rare
entity among head and neck malignancies.
Furthermore, most of them are chondrosarco-
mas, and the osteogenic form remains a true
rarity. In general, there is a lack of information
on the characteristics of laryngeal osteosar-
coma. Thus, we sought to critically review the
existing world literature on laryngeal osteosar-
coma in order to develop a more accurate clin-
icopathological profile of this malignancy.
Laryngeal osteosarcoma has a predilection for
elderly male patients, as 87% were male in the
present series and the mean age was 62 years
(range 32–80), and without a direct association
with tobacco exposure. Osteosarcoma of the
larynx is typically a highly malignant neoplasm
that metastasizes early, has a propensity for
hematogenous spread and also has a marked
tendency to recur. Twelve (41%) out of the 29
cases in the present review with follow-up data
had metastatic disease. The aspects that distin-
guish osteosarcoma from its differential diag-
nostic alternatives are discussed in this review.
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Key Summary Points
Laryngeal sarcomas constitute an
extremely rare entity among head and
neck malignancies.
Osteosarcoma of the larynx is typically a
highly malignant neoplasm that
metastasizes early, has a propensity of
hematogenous spread and also has a
marked tendency to recur.
A full photomicrographic documentation
is essential for the diagnosis and
registration of osteosarcoma cases.
The diagnosis of this highly malignant
tumor would preferably warrant an
international consultation network
including a registry of rare head and neck
neoplasms.
INTRODUCTION
Despite being the most common primary
malignant neoplasm of the bony skeleton,
osteosarcoma is one of the rarest malignant
mesenchymal neoplasms of the larynx. Sarco-
mas encountered in the larynx are usually
chondrosarcomas. Therefore, even physicians
in referral-based academic centers of pathology
or otorhinolaryngology–head and neck surgery
may encounter only a single patient with a true
laryngeal osteosarcoma in their entire career. Of
note, we searched the REFCOR database (re´seau
d’Expertise Franc¸ais sur les Cancers ORL Rares
[French Network of Rare Head and Neck
Tumors]) in order to find cases to report in the
present review. The REFCOR has been register-
ing rare head and neck cancers, i.e., rare cancers
of the aerodigestive tract excluding squamous
cell carcinoma and undifferentiated nasopha-
ryngeal carcinoma, and cancers of the salivary
glands, ear, nasal cavities, and sinus, since 2008.
Out of the 7530 patients registered up to August
2019, only 54 osteosarcoma cases were diag-
nosed, and none of these was located in the
larynx.
Laryngeal osteosarcoma was first described
by Jackson and Jackson in 1942 without histo-
logical documentation [1]. In 1946, Clerf et al.
reported eight cases of sarcoma of the larynx,
and one of these was classified as fibro-os-
teosarcoma, but the photomicrograph of the
tumor was not convincing [2]. The first well-
documented case of laryngeal osteosarcoma was
described by Sprinkle et al. in 1966 [3]. Of note,
in 1974, the textbook Tumors of the Head and
Neck: Clinical and Pathological Considerations by
Batsakis concluded that no authentic case of
osteosarcoma in the upper respiratory tract,
including the larynx, had been reported at that
time [4]. In 2017, Bennion et al. reported 33
laryngeal osteosarcomas having been reported
in the English literature since 1942, but many of
the reports listed in their review, including their
own cases, did not present pathological docu-
mentation [5].
It is noteworthy that morphological features
of sarcomas typically represent a heterogeneous
variation in morphology. This will lead to
challenging differential diagnostic considera-
tions, especially when the obtained biopsies
remain small. In contrast to a low-grade chon-
drosarcoma—in which a limited biopsy speci-
men may still leave open the question of the
malignant nature of that lesion—it is usually
quite apparent for the pathologist that a laryn-
geal osteosarcoma specimen represents a high-
grade malignancy. More importantly, the
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precise subclassification of the malignancy will
need to be determined.
The existing reports of laryngeal osteosar-
coma cases do not consistently include patho-
logical documentation that would allow critical
evaluation of the final pathological diagnosis.
Therefore, our primary aim was to create a cur-
rent series of all the published laryngeal
osteosarcoma cases by critically evaluating the
published reports of this rare malignancy and to
include only those cases with adequate patho-
logical description of the findings. The secondary
aim was to obtain comprehensive information
regarding the characteristics of these neoplasms
to enable a discussion of possibilities for
enhancing their diagnostic accuracy.
METHODS
We conducted a literature search in the PubMed
database using the following keywords: ‘‘La-
ryngeal’’ OR ‘‘Larynx’’ AND ‘‘Osteosarcoma’’.
The search covered all years from the origin of
the database until 31 December 2019. The Pre-
ferred Reporting Items for Systematic Review
and Meta-Analysis (https://www.equator-
network.org/) methodology was applied. A
total of 61 hits were retrieved (Fig. 1). Of these,
30 publications were relevant as having repor-
ted a new case/s of laryngeal osteosarcoma
(N = 33) that met the inclusion criteria of pro-
viding proper pathological evaluation and
photomicrographic documentation of the
finding. Cases that did not meet these inclusion
criteria were excluded. This article is based on
previously conducted studies and does not
contain any studies with human participants or
animals performed by any of the authors.
RESULTS AND DISCUSSION
Clinical Features of the Reported Cases
in the Literature
Many reports indicate that this neoplasm occurs
in men in their sixth and eighth decades of life,
and that the lesion is not directly associated with
alcohol or tobacco exposure [6, 7]. Laskin et al.
and Sheen et al. reported two patients with a
history of radiotherapy prior to the development
of laryngeal osteosarcoma [8, 9]. These tumors
usually arise from the vocal cord and cricoid
cartilage. Therefore, the most common symp-
toms are hoarseness, dyspnea, and obstruction.
Fig. 1 Flow chart describing the PRISMA search
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The tumors included in this review and with
information on the exact location (N = 22)
involved either subglottic [2], supraglottic [3] or
transglottic [2] structures, vocal cords [10], or
thyroid and/or cricoid cartilages [6].
Osteosarcoma is typically a highly malignant
neoplasm that metastasizes early, with a
propensity for hematogenous spread and also a
marked tendency to recur. There are reports of
metastases to regional lymph nodes, but these
remain rare, and instead, hematogenous spread
to the lungs is the main route. In the present
review, 12 out of the 33 patients were diagnosed
with distant metastases, most frequently in the
lungs. Seventeen out of the 25 patients with
follow-up data available in the published case
reports had experienced persistent or early
recurrent disease, typically within 1–2 years.
Pathology of Laryngeal Osteosarcoma
Macroscopically, the neoplasm is mainly poly-
poid or exophytic in appearance but may also
mimic other sarcomas. The gross specimen is
typically grainy and, in some areas, difficult or
impossible to cut with a scalpel because of its
ossification. The tissue may have a variable
color ranging from yellow to brown or red.
Microscopically, the tumor is composed of
frankly malignant, spindle-shaped mesenchy-
mal cells, associated with osteoid and immature
neoplastic bone formation, as was shown in the
reviewed reports (Fig. 2). The nuclei show con-
siderable hyperchromasia or pleomorphism,
and mitoses may be numerous. Atypical and
bizarre giant cells and multinucleated osteo-
clast-like cells have been described. Venous
invasions may be identified.
Immunohistochemical staining has shown
that the neoplasm is positive for vimentin and
negative for desmin, S-100 protein, cytokeratin
(AE1/AE3, MNF-116, CK5/6, CK7, CK8, CK19,
CK20), and epithelial membrane antigen. Both
osteonectin and osteocalcin are expressed in
osteogenic sarcoma but are not sufficiently
specific. However, osteonectin and osteocalcin
will highlight osteoid matrix and distinguish it
from collagen matrix.
Electron microscopy studies [10–12] have
shown cells resembling osteoblasts with
Fig. 2 a Laryngeal osteosarcoma with osteoid formations
(arrow) produced by malignant cells (hematoxylin–eosin).
b Osteoid formation (arrows) by the tumor cells is readily
apparent and confirms the diagnosis of osteosarcoma
(hematoxylin–eosin). c Another area of the tumor-
producing osteoid (arrows) (hematoxylin–eosin)
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pleomorphic nuclei and nucleoli of variable size
within the abundant cytoplasm containing
numerous dilated cisternae of rough endoplas-
mic reticulum. The cells were enveloped by
interlacing collagen fibers. Osteoblastic ele-
ments predominated but cartilaginous and
fibrous tissue could also be found. No desmo-
somes or other evidence of epithelial differen-
tiation was found in the tumor.
Diagnosis of Laryngeal Osteosarcoma
The definite diagnosis of osteosarcoma depends
on the identification of osteoid production by
malignant cells in the biopsy sample, as was
shown in the reviewed reports. The differential
diagnosis includes spindle-cell squamous carci-
noma with osteoid differentiation, chondrosar-
coma, malignant fibrous histiocytoma,
fibrosarcoma, and myositis ossificans affecting
the larynx. Spindle-cell squamous carcinoma
may contain benign and rarely malignant
osteoid areas [13]. Therefore, older reports of
laryngeal osteosarcoma may represent spindle-
cell squamous carcinoma with osteoid forma-
tion. Any bone-producing malignant mes-
enchymal lesion should at first be suspected as a
spindle-cell carcinoma. The presence of islands
of carcinoma in situ or microinfiltrating carci-
noma excludes the diagnosis of osteosarcoma.
In osteogenic sarcoma, clearly sarcomatous
areas are present, and the ‘‘zonal phe-
nomenon’’—which is characterized by a central
cellular area, an intermediate zone of osteoid
formation, and a peripheral shell of highly
organized bone—is absent. The phenomenon of
formation of mature bone is most prominent in
the periphery of the lesion and is an important
criterion for differentiating myositis ossificans
from osteogenic sarcoma. In this latter lesion,
mature osteoids are located in the center of
neoplasm, and neoplastic mesenchymal cells—
that form the osteoids—are in the periphery.
Osteogenic sarcoma metastatic to larynx has
also been reported [14, 15]. This unlikely event
can be ruled out with clinical assessment of the
patient.
Treatment and Prognosis
Wide local resection with clear margins, which
typically warrants total laryngectomy, remains
the treatment of choice for laryngeal osteosar-
coma to achieve local control and long-term
Table 1 Key features of laryngeal osteosarcoma
Rarity
Demographics
Large lesions arising predominantly in men in their sixth to eight decades
Histology
High-grade sarcoma with area of osteoid production by the tumor cells at least focally
Chondroid elements may be present, as may areas reminiscent of fibrosarcoma, malignant
Fibrous histiocytoma, or sarcoma (not further subclassified)
Immunohistochemical staining can be utilized and will add to the histological diagnosis
Differential diagnosis
Spindle-cell squamous carcinoma with osteoid differentiation, chondrosarcoma, malignant fibrous histiocytoma,
fibrosarcoma, and myositis ossificans
Prognosis
Laryngeal osteosarcoma usually results in death in less than 2 years from either extensive local disease or pulmonary
metastases
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Table 2 Cases of laryngeal osteosarcoma with pathological documentation
Institute Authors Year Characteristics and treatment Follow-up
University of Washington, Seattle,
WA, USA
Mantilla et al.
[38]
2019 75/M. Former smoker. Progressive
hoarseness. Anterior commissure
Lost to follow-up
High-grade. No invasion of TC. No
Metastasis. LE
Rashid Hospital, Dubai AbdullGaffar
and Keloth
[16]
2018 32/F. Non-smoker. Hoarseness for
1.5 months
Lost to follow-up
Subglottic, 1.5 cm. Small-cell OS
Chandigarh, India Bahl et al. [6] 2015 50/M. Hoarseness for 2 months NED at 9 months
Transglottic. No metastases. LE,
thyroidectomy, partial
pharyngectomy. CT
Nicolaus Copernicus University,
Torun, Poland
Sawicki et al.
[17]
2015 58/F. Dyspnea for 6 months NED[ 22 months
Subglottic. Immobile VC. No
metastases. LE
Tygerberg Hospital, Cape Town,
South Africa
Mosalleum et al.
[7]
2015 55/M. Former smoker (2PY) Bilateral lung
metastases at
8 months
Dysphonia, dyspnea for 4 months.
LE
Saitama Medical University,
International Medical Center,
Hidaka, Saitama, Japan
Kuba et al. [18] 2015 55/M. Non-smoker. Odynophagia NED at 20 months
Neck mass
High-grade osteoblastic OS
No metastases. Partial LE
Baroda, Gujarat, India Bhatt et al. [19] 2014 38/M. Smoker. Hoarseness for
2 months. No metastases
NED at 15 months
Near-total LE
Istanbul University, Turkey Ulusan et al.
[20]
2012 59/M. Smoker. Hoarseness and
dyspnea. Anterior commissure
NED at 8 years
Radiation-induced OS (RT 5 years
earlier). Normal chest, abdominal,
and bone radiographs. No
metastasis
LE
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Table 2 continued
Institute Authors Year Characteristics and treatment Follow-up
Tabriz University Tabriz, Iran Sanaat et al.
[21]
2009 71/M. Smoker. True and false cords DOD at
12 months
Dyspnea, dysphagia, and
odynophagia
Solid mass destroying both cords
with supra- and subglottic
extension
Bone and lung metastases. LE
Sisli Etfal Education & Research,
Hospital, Department of
Radiation Oncology, Istanbul,
Turkey
Arslan et al.
[22]
2008 69/M. Larynx. NOS. Persistent
hoarseness. LE and postoperative
RT. Neck recurrence 5 months
later
DOD
Lung and neck metastases
Hospital San Giovanni, di Dio e
Ruggi d’Aragona, Via San
Leonardo, Salerno, Italy
Mottola et al.
[23]
2008 56/M. Non-smoker. TC, CC, and
paratracheal space. Dyspnea,
dysphagia, and dysphonia. Tumor
mass affecting glottis and
supraglottis. LE
DOD 3 months
Oddział Otolaryngologiczny Szpitala
im. F. Raszei w Poznaniu
Rydzewki et al.
[24]
2005 Bilateral neck and lung metastases
LE, ND, and CT
DOD
University of Texas, Southwestern
Medical Center, Dallas, TX, USA
Athre´ et al. [25] 2005 69/F. Progressive dyspnea. Larynx,
strap muscles, and thyroid gland
DOD at
10 months
Dystrophic calcification outside
laryngeal confines. Total LE,
pharyngectomy, esophagectomy
Lung metastasis
Departments of ORL and Pathology
Okmeydanı Training Hospital,
Istanbul, Turkey
Topaloglu et al.
[26]
2004 80/M. RVC, LVC, and ventricular
bands. Hoarseness, progressive
dyspnea. Soft tissue mass
narrowing the airway. Extended
LE
NED 15 months
M.D. Anderson Cancer Center,
Houston, TX, US
Madrigal et al.
[27]
2002 50/M. RVC. Hoarseness. Partial
frontolateral LE
NED at 24 months
59/M. Smoker. TC. Hoarseness.
Destructive lesion of the TC
extending to parapharyngeal soft
tissue. Total LE, CRT. Multiple
lung metastases
DOD 18 at
months
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Table 2 continued
Institute Authors Year Characteristics and treatment Follow-up
60/M. Smoker. Polypoid mass of the
RVC with anterior commissure
extension. Dyspnea. LE and CRT
NED at 60 months
Neck recurrence 10 months later
69/M. Smoker. True vocal cord Lost to follow-up
Dyspnea, dysphonia, and cough
Lung metastases
Ohio State University, OH, USA Rossi et al. [28] 1998 68/M. Former smoker DOD at 3 months
Wide-field LE. Lung metastases
The Long Island Jewish Medical
Center. The Long Island Campus
of the Albert Einstein College of
Medicine, New Hyde Park, NY,
USA
Myssiorek et al.
[29]
1998 47/M. Smoker. TC. Hoarseness,
dyspnea, otalgia, hemoptysis
DOD at
12 months
Destructive lesion of TC with
extension into soft tissues.
LE. Bone metastasis
University of Pittsburgh, Medical
Center, Pittsburgh, PA, USA
Berge et al. [30] 1998 60/F. Non-smoker. CC. Dysphonia,
dysphagia, and weight loss
NED at 44 months
Expansion of the medullary portion
of the cricoid cartilage with
encroachment on the airway
LE and ND
National Taiwan University
Hospital, Taipei, Taiwan
Sheen et al. [9] 1997 56/M. RT for nasopharyngeal
carcinoma 32 years earlier
DOD at
21 months
Left neck and anterior TC
Hoarseness. Hyperdense mass in the
left upper neck. LE
Institute AFIP Devaney and
Ferlito [31]
1996 Pathology consultation case Lost to follow-up
Hasharon Hospital, Golda Medical
Center, Petah Tikva
Zohar et al.
[32]
1996 Surgery Lost to follow-up
Centre Hospitalier Universitaire, de
Bordeaux, France
Pinsolle et al.
[12]
1990 65/M. Former smoker. Dyspnea,
dysphonia. 1.5 cm polypoid tumor
involving the RVC and anterior
commissure. RT
NED at 60 months
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Table 2 continued
Institute Authors Year Characteristics and treatment Follow-up
Recurrence after 1 month
Resection and pectoralis flap
University of Liverpool, England Van Laer et al.
[33]
1989 75/M. LVC and left pyriform fossa Recurrence at
13 months
Dysphagia, discomfort in the throat
Amorphous mass of calcification. LE
Pathologisches Institut Oldenburg,
Germany
Remagen et al.
[34]
1983 65/M. LVC. RT. Recurrent disease DOD at
24 months
Mayo Clinic, Rochester, NY, USA Gorenstein
et al. [35]
1980 75/M. RVC and ventricle DOD at
14 months
Hoarseness 5 months. LE and ND
Local and distant metastases
Mahidol University, Bangkok,
Thailand,
Suchatlampong
et al. [11]
1981 67/M. LVC, anterior and posterior
commissure and supraglottis
DOD at 6 months
Hoarseness and dyspnea. Mass
involving the glottis with
supraglottic extension. RT
University of Texas, Southwestern
Medical School, Dallas, TX, USA
Dahm et al.
[10]
1978 79/M. RVC and anterior
commissure
DOD
Hoarseness and difficulty breathing
Polypoid mass occupying the airway
Multiple lung metastases. LE
State Univ. of New York, Buffalo,
NY, USA
Haar et al. [36] 1978 66/M. Smoker. Hoarseness. CC,
posterior wall of the proximal
trachea and displacing the
esophagus anteriorly
DOD at
21 months
Lung metastasis. LE
Royal Victoria Infirmary, Newcastle,
UK
Morley et al.
[37]
1973 62/M. Hoarseness, dyspnea, acute
respiratory obstruction. Occasions
of loss of consciousness. Polypoid
lesion of RVC
DOD at 3 months
LVC with supraglottic extension
Subtotal LE and RT
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survival. In the present cases, laryngectomy was
performed for 26 out of the 29 cases with
treatment-related data available. Adjuvant
radiotherapy needs to be considered individu-
ally, as osteosarcomas are relatively radioresis-
tant. Chemotherapy might improve the
prognosis for patients with disseminated
lesions, and it should be emphasized that in the
results of the present review, the number of
patients with distant metastasis was high (36%).
In the present review, five out of the 33
patients had no reported follow-up data. Eleven
out of the 28 patients with follow-up data
available were alive with no evidence of disease
after a variable follow-up time (range 9 months
to 8 years).
The important features of laryngeal
osteosarcoma are summarized in Table 1. A
summary of the reported laryngeal osteosar-
coma cases is shown in Table 2, with the first
case published in 1966 [3] and the last in 2019
[38]. Table 3 provides a description of the cases
that have been reported without pathological
documentation.
CONCLUSIONS
True laryngeal osteosarcoma remains an extre-
mely rare malignancy. The true incidence of
this entity is not known but based on the
number of existing well-documented cases
(n = 33) in the literature during 1966–2019, it is
obviously not encountered at most of the
institutions managing laryngeal tumors.
The diagnosis of this highly malignant
tumor would preferably warrant an interna-
tional consultation network including a registry
of rare head and neck neoplasms. Electronic
platforms for such activities exist. Our review
demonstrates that full photomicrographic doc-
umentation is essential for the diagnosis and
registration of osteosarcoma cases. Further-
more, such a collaborative effort would enable
multidisciplinary recommendations for indi-
vidual management as well. Naturally, man-
agement of laryngeal osteosarcoma should be
Table 2 continued
Institute Authors Year Characteristics and treatment Follow-up
Univ. of Virginia, Charlottesville,
VA, USA
Sprinkle et al.
[3]
1966 71/M. Hoarseness. Posterior surface
of RVC. No metastasis. LE
NED[ 24 months
F female, M male, OS osteosarcoma, LE laryngectomy, ND neck dissection, Tx treatment, NED no evidence of disease, PY
pack years, RT radiotherapy, CT chemotherapy, CRT chemoradiotherapy, DOD dead of disease, TC thyroid cartilage, CC
cricoid cartilage, RVC right vocal cord, LVC left vocal cord, ND neck dissection
Table 3 Reported cases of laryngeal osteosarcoma with no
pathological documentation
Bennion et al.
[5]
2017 48/F. Shortness of breath.
Erythematous mass inferior to
the level of the true vocal cords
at the posterior commissure.
The tumor appeared to arise
from the cricoid cartilage in
computed tomography imaging.
No microphotography
Laskin et al.
[8]
1988 56/M. Three years after
radiotherapy. No follow-up
data. No microphotography
Clerf et al. [2] 1946 51/M. Hoarseness and dyspnea.
Later with local recurrence and
lung metastasis. DOD
14 months. Pathological
documentation not convincing
Jackson and
Jackson [1]
1942 51/M. Hoarseness, dyspnea, and
dysphagia. Cricoid cartilage.
Local recurrence after 3 months.
DOD after 6 months with
mediastinal metastasis. No other
data available
F female, M male, DOD dead of disease
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centralized to a few experienced tertiary care
academic centers.
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